Lanzamiento Enero 2027

Ensayo controlado aleatorizado2009Financiado por la industria

Financiado en parte por Teva Pharmaceutical Industries

Olive oil-based intravenous lipid emulsion in pediatric patients undergoing bone marrow transplantation: a short-term prospective controlled trial

Hartman C, Ben-Artzi E, Berkowitz D, Elhasid R, Lajterer N, Postovski S, Hadad S, Shamir R

Clinical nutrition (Edinburgh, Scotland) · 15 citas

Etiquetas de revisión

Financiado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiado por la industria
Empresa
Teva Pharmaceutical Industries

Según 1 financiador declarado.

Publicación

Publicado
2009-06-04 · Clin Nutr · vol. 28 · número 6 · págs. 631–635
Editorial
Elsevier BV
Citado
21 citas · más que el 76% de estudios similares · 0.8× el promedio de su campo
Referencias
36 trabajos
Acceso
De pago
Áreas de investigación
Clinical Nutrition and Gastroenterology · Central Venous Catheters and Hemodialysis · Fatty Acid Research and Health
Palabras clave
intravenous lipid emulsion, parenteral nutrition, pediatric bone marrow transplantation, medium-chain triglycerides, long-chain triglycerides, plasma fatty acid profile, vitamin E, lipid peroxidation, cholesterol, oleic acid, arachidonic acid, engraftment
MeSH
humans, thiobarbituric acid reactive substances, vitamin e, lipids, fat emulsions, intravenous, plant oils, liver function tests, parenteral nutrition, bone marrow transplantation, prospective studies, lipid peroxidation, adolescent, child, child, preschool, infant, olive oil

8 autores

  • Corina Hartman🇮🇱 · autor de correspondenciaTel Aviv University; Schneider Children's Medical Center
  • Elisheva Ben‐Artzi🇮🇱Bar-Ilan University; Kinneret College on the Sea of Galilee
  • Drora Berkowitz🇮🇱Rambam Health Care Campus; Meyer Children's Hospital
  • Ronit Elhasid🇮🇱Rambam Health Care Campus; Meyer Children's Hospital
  • Noah Lajterer🇮🇱Rambam Health Care Campus; Meyer Children's Hospital
  • Sergey Postovsky🇮🇱Rambam Health Care Campus; Meyer Children's Hospital
  • Salim Hadad🇮🇱Rambam Health Care Campus
  • Raanan Shamir🇮🇱Tel Aviv University; Schneider Children's Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background & aims

Parenteral nutrition (PN) is an important component of the supportive care of children undergoing bone marrow transplantation (BMT). The study aimed to assess short-term safety and metabolic effects of an olive oil-based (OO) lipid emulsion compared with a MCT/LCT (M/L) emulsion in the clinical setting of pediatric BMT.

Methods

Twenty-eight pediatric BMT patients (age 1-18 years) expected to need PN support for at least 2 weeks, were prospectively enrolled and randomly assigned to receive either OO or M/L lipid emulsions within PN. Clinical and routine laboratory parameters, plasma fatty acids profile, vitamin E and peroxidation status were recorded at baseline and after 14 days of PN.

Results

No significant differences were found for hematological parameters, liver enzymes, vitamins, plasma peroxidation status, percentage and time to engraftment. Taking into consideration the baseline fatty acids levels, the OO group showed higher oleic acid (p=0.012), linoleic (p=0.012) and arachidonic acid (p=0.002) enrichment but similar eicosapentanoic and docosahexanoic acids levels compared to the M/L group at day 14. Cholesterol levels decreased significantly in the OO group after 14 days on PN (p=0.017).

Conclusions

OO lipid emulsion was well tolerated, maintained essential fatty acids and peroxidation status, and generated a favorable plasma lipid profile. In this study short-term use of OO intravenous lipid emulsions was safe in children who needed PN support during BMT.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.